Owner PHARMACIA CORPORATION

Inventors HOCKERMAN, Susan L.; KASSAB, Darren, J.; KOLODZIEJ, Steve, A.; MCDONALD, Joseph, J.; NORTON, Monica, B.; RICO, Joseph, G.; TALLEY, John, J.; VILLAMIL, Clara, I.; WANG, Tijuan, Jane; BARTA, Thomas, E.; BECKER, Daniel, P.; BEDELL, Louis, J.; BOEHM, Terri, L.; FOBIAN, Yvette, M.; FRESKOS, John, N.

Pub. Number AU-A-2002259212

PCT Pub. Number WO2002/092588

Priority 60/290,375 11.05.01 US

Filing date 10 May 2002

Wipo publication date 25 November 2002

C07D 309/08 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 211/66 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 407/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 031/351 - not condensed with another ring

A61P 035/00 Antineoplastic agents